Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Mar;81(3):635–640. doi: 10.1172/JCI113366

Sorbitol, osmoregulation, and the complications of diabetes.

M B Burg 1, P F Kador 1
PMCID: PMC442508  PMID: 3278002

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akagi Y., Kador P. F., Kinoshita J. H. Immunohistochemical localization for aldose reductase in diabetic lenses. Invest Ophthalmol Vis Sci. 1987 Jan;28(1):163–167. [PubMed] [Google Scholar]
  2. Akagi Y., Terubayashi H., Millen J., Kador P. F., Kinoshita J. H. Aldose reductase localization in dog retinal mural cells. Curr Eye Res. 1986 Nov;5(11):883–886. doi: 10.3109/02713688609029241. [DOI] [PubMed] [Google Scholar]
  3. Bagnasco S. M., Uchida S., Balaban R. S., Kador P. F., Burg M. B. Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl. Proc Natl Acad Sci U S A. 1987 Mar;84(6):1718–1720. doi: 10.1073/pnas.84.6.1718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bagnasco S., Balaban R., Fales H. M., Yang Y. M., Burg M. Predominant osmotically active organic solutes in rat and rabbit renal medullas. J Biol Chem. 1986 May 5;261(13):5872–5877. [PubMed] [Google Scholar]
  5. Balaban R. S., Burg M. B. Osmotically active organic solutes in the renal inner medulla. Kidney Int. 1987 Feb;31(2):562–564. doi: 10.1038/ki.1987.36. [DOI] [PubMed] [Google Scholar]
  6. Bedford J. J., Bagnasco S. M., Kador P. F., Harris H. W., Jr, Burg M. B. Characterization and purification of a mammalian osmoregulatory protein, aldose reductase, induced in renal medullary cells by high extracellular NaCl. J Biol Chem. 1987 Oct 15;262(29):14255–14259. [PubMed] [Google Scholar]
  7. Chylack L. T., Jr, Tung W., Harding R. Sorbitol production in the lens: a means of counteracting glucose-derived osmotic stress. Ophthalmic Res. 1986;18(5):313–320. doi: 10.1159/000265455. [DOI] [PubMed] [Google Scholar]
  8. Cunha-Vaz J. G., Mota C. C., Leite E. C., Abreu J. R., Ruas M. A. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy. Diabetes. 1986 May;35(5):574–578. doi: 10.2337/diab.35.5.574. [DOI] [PubMed] [Google Scholar]
  9. Datiles M. B., Kador P. F., Fukui H. N., Hu T. S., Kinoshita J. H. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci. 1983 May;24(5):563–569. [PubMed] [Google Scholar]
  10. Engerman R. L., Kern T. S. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 1984 Jan;33(1):97–100. doi: 10.2337/diab.33.1.97. [DOI] [PubMed] [Google Scholar]
  11. Fagius J., Jameson S. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study. J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991–1001. doi: 10.1136/jnnp.44.11.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Greene D. A., Lattimer S. A., Sima A. A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med. 1987 Mar 5;316(10):599–606. doi: 10.1056/NEJM198703053161007. [DOI] [PubMed] [Google Scholar]
  13. Griffey R. H., Eaton R. P., Gasparovic C., Sibbitt W. Galactose neuropathy. Structural changes evaluated by nuclear magnetic resonance spectroscopy. Diabetes. 1987 Jun;36(6):776–778. doi: 10.2337/diab.36.6.776. [DOI] [PubMed] [Google Scholar]
  14. Jaspan J. B., Towle V. L., Maselli R., Herold K. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes. Metabolism. 1986 Apr;35(4 Suppl 1):83–92. doi: 10.1016/0026-0495(86)90193-9. [DOI] [PubMed] [Google Scholar]
  15. Judzewitsch R. G., Jaspan J. B., Polonsky K. S., Weinberg C. R., Halter J. B., Halar E., Pfeifer M. A., Vukadinovic C., Bernstein L., Schneider M. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med. 1983 Jan 20;308(3):119–125. doi: 10.1056/NEJM198301203080302. [DOI] [PubMed] [Google Scholar]
  16. Kador P. F., Kinoshita J. H., Sharpless N. E. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J Med Chem. 1985 Jul;28(7):841–849. doi: 10.1021/jm00145a001. [DOI] [PubMed] [Google Scholar]
  17. Kern T. S., Engerman R. L. Hexitol production by canine retinal microvessels. Invest Ophthalmol Vis Sci. 1985 Mar;26(3):382–384. [PubMed] [Google Scholar]
  18. Kinoshita J. H. Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol. 1974 Oct;13(10):713–724. [PubMed] [Google Scholar]
  19. Matsuda M., Awata T., Ohashi Y., Inaba M., Fukuda M., Manabe R. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats. Curr Eye Res. 1987 Feb;6(2):391–397. doi: 10.3109/02713688709025192. [DOI] [PubMed] [Google Scholar]
  20. Robison W. G., Jr, Kador P. F., Akagi Y., Kinoshita J. H., Gonzalez R., Dvornik D. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes. 1986 Mar;35(3):295–299. doi: 10.2337/diab.35.3.295. [DOI] [PubMed] [Google Scholar]
  21. Schultz R. O., Matsuda M., Yee R. W., Edelhauser H. F., Schultz K. J. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol. 1984 Oct 15;98(4):401–410. doi: 10.1016/0002-9394(84)90120-x. [DOI] [PubMed] [Google Scholar]
  22. Seland J. H., Chylack L. T., Jr Acute glucose-derived osmotic stress in rabbit lenses. Acta Ophthalmol (Copenh) 1986 Oct;64(5):533–539. doi: 10.1111/j.1755-3768.1986.tb06968.x. [DOI] [PubMed] [Google Scholar]
  23. Somero G. N. Protons, osmolytes, and fitness of internal milieu for protein function. Am J Physiol. 1986 Aug;251(2 Pt 2):R197–R213. doi: 10.1152/ajpregu.1986.251.2.R197. [DOI] [PubMed] [Google Scholar]
  24. Tomlinson D. R., Holmes P. R., Mayer J. H. Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett. 1982 Aug 16;31(2):189–193. doi: 10.1016/0304-3940(82)90115-x. [DOI] [PubMed] [Google Scholar]
  25. Uchida S., Green N., Coon H., Triche T., Mims S., Burg M. High NaCl induces stable changes in phenotype and karyotype of renal cells in culture. Am J Physiol. 1987 Aug;253(2 Pt 1):C230–C242. doi: 10.1152/ajpcell.1987.253.2.C230. [DOI] [PubMed] [Google Scholar]
  26. Yancey P. H., Clark M. E., Hand S. C., Bowlus R. D., Somero G. N. Living with water stress: evolution of osmolyte systems. Science. 1982 Sep 24;217(4566):1214–1222. doi: 10.1126/science.7112124. [DOI] [PubMed] [Google Scholar]
  27. Young R. J., Ewing D. J., Clarke B. F. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 1983 Oct;32(10):938–942. doi: 10.2337/diab.32.10.938. [DOI] [PubMed] [Google Scholar]
  28. Yue D. K., Hanwell M. A., Satchell P. M., Turtle J. R. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes. 1982 Sep;31(9):789–794. doi: 10.2337/diab.31.9.789. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES